Helicobacter pylori eradication in Parkinson's disease: A double-blind randomized placebo-controlled study

被引：0
|
作者：
Tan, A. H. [1 ]
Lim, S. Y. [1 ]
Mahadeva, S. [1 ]
Loke, M. F. [1 ]
Vadivelu, J. S. [1 ]
Marras, C. [1 ]
Fox, H. [1 ]
Lang, A. E. [1 ]
机构：
[1] Univ Malaya, Kuala Lumpur, Malaysia
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
954
引用
收藏
页码：S422 / S425
页数：4
相关论文
共 50 条
  • [1] Probiotics for Standard Triple Helicobacter pylori Eradication A Randomized, Double-blind, Placebo-controlled Trial
    Hauser, Goran
    Salkic, Nermin
    Vukelic, Karina
    JajacKnez, Alenka
    Stimac, Davor
    [J]. MEDICINE, 2015, 94 (17) : e685
  • [2] Helicobacter pylori eradication and gastric preneoplastic conditions:: A randomized, double-blind, placebo-controlled trial
    Ley, C
    Mohar, A
    Guarner, J
    Herrera-Goepfert, R
    Figueroa, LS
    Halperin, D
    Johnstone, I
    Parsonnet, J
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (01) : 4 - 10
  • [3] Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy -: a placebo-controlled, double-blind randomized pilot study
    Myllyluoma, E
    Veijola, L
    Ahlroos, T
    Tynkkynen, S
    Kankuri, E
    Vapaatalo, H
    Rautelin, H
    Korpela, R
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (10) : 1263 - 1272
  • [4] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    [J]. MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [5] Rivastigmine in dementia associated with Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Emre, M.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 298 - 298
  • [6] Mucuna pruriens in parkinson's disease: a double-blind, randomized, placebo-controlled, crossover study
    Cilia, R.
    Laguna, J.
    Cassani, E.
    Cereda, E.
    Pezzoli, G.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E262 - E263
  • [7] Atomoxetine for the Treatment of Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
    Weintraub, Daniel
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A67 - A67
  • [8] Inhibitory effects of β-caryophyllene on Helicobacter pylori infection: a randomized double-blind, placebo-controlled study
    Shim, H.
    Cho, J.
    Shin, C.
    Yoon, H.
    Park, Y.
    Kim, N.
    Lee, D.
    [J]. HELICOBACTER, 2019, 24
  • [9] Inhibitory effects of β-caryophyllene on Helicobacter pylori infection: a randomized double-blind, placebo-controlled study
    Shim, Hyun Ik
    Cho, Jae Ho
    Shin, Cheol Min
    Yoon, Hyuk
    Park, Young Soo
    Kim, Nayoung
    Lee, Dong Ho
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 324 - 324
  • [10] A randomized, double-blind, placebo-controlled study of atornoxetine for freezing of gait in Parkinson's disease
    Nashatizadeh, M. M.
    Jimenez, J. E.
    Davidson, A. L.
    Jankovic, J.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S219 - S219
12345